The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Therapeutic approaches to Alzheimer's disease
Open accessAbstract
Alzheimer's disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia affecting approximately 5% of adults over 65 years. In view of our ageing society the number of patients, as well as the economical and social impact, is expected to grow dramatically in the future. Currently available medications appear to be able to produce moderate symptomatic benefits but not to stop disease progression. The search for novel therapeutic approaches targeting the presumed underlying pathogenic mechanisms has been a major focus of research and it is expected that novel medications with disease-modifying properties will emerge from these efforts in the future. In this review, currently available drugs as well as novel therapeutic strategies, in particular those targeting amyloid and tau pathologies, are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–246 of 246
Whitehead, A., Perdomo, C. A., Pratt, R. D., Birks, J., Wilcock, G. K., & Evans, J. G. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1133 · Cited by 155
Tau Protein in Normal and Alzheimer's Disease Brain: An Update
Johnson, G. V. W., & Hartigan, J. A. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-512 · Cited by 154
Li, L., Sengupta, A., Haque, N., Grundke, I., & Iqbal, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.047 · Cited by 154
Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation
Iqbal, K., Zaidi, T., Bancher, C., & Grundke, I. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00650-4 · Cited by 150
Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
Lombardo, J. A., Stern, E. A., McLellan, M. E., Kajdasz, S. T., Hickey, G. A., Bacskai, B. J., & Hyman, B. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10879.2003 · Cited by 149
Hartman, R. E., Izumi, Y., Bales, K. R., Paul, S. M., Wozniak, D. F., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0664-05.2005 · Cited by 147
Lemere, C. A., Spooner, E. T., LaFrancois, J., Malester, B., Mori, C., Leverone, J. F., Matsuoka, Y., Taylor, J. W., DeMattos, R. B., Holtzman, D. M., et al. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00044-5 · Cited by 142
Du, Y., Wei, X., Dodel, R., Sommer, N., Hampel, H., Gao, F., Ma, Z., Zhao, L., Oertel, W. H., & Farlow, M. (2003) · Brain · doi:10.1093/brain/awg191 · Cited by 138
Roder, H. M., & Ingram, V. M. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03325.1991 · Cited by 133
Glutamate and the glutamate receptor system: a target for drug action
Bleich, S., R�mer, K., Wiltfang, J., & Kornhuber, J. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.933 · Cited by 127
Self-citationLigand-Dependent Inhibition and Reversal of Tau Filament Formation
Chirita, C. N., Necula, M., & Kuret, J. (2004) · Biochemistry · doi:10.1021/bi036094h · Cited by 116
Frölich, L. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200083 · Cited by 110
Reappraisal of the fine structure of Alzheimer's neurofibrillary tangles
Yagishita, S., Itoh, Y., Nan, W., & Amano, N. (1981) · Acta Neuropathologica · doi:10.1007/bf00687747 · Cited by 109
Pubertal Changes in Biochemical Markers of Growth
Federico, G., Baroncelli, G. I., Vanacore, T., Fiore, L., & Saggese, G. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071225 · Cited by 102
Characterization of two pathological Tau protein variants in Alzheimer brain cortices
Flament, S., Delacourte, A., Hémon, B., & Défossez, A. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90131-7 · Cited by 101
Friedhoff, L. T., Cullen, E. I., Geoghagen, N. S. M., & Buxbaum, J. D. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002310 · Cited by 97
Fukutani, Y., Kobayashi, K., Nakamura, I., Watanabe, K., Isaki, K., & Cairns, N. J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12083-g · Cited by 96
Re-assessing the relationship between cholesterol, statins and Alzheimer's disease
Wolozin, B. L., Manger, J., Bryant, R. A., Cordy, J. M., Green, R. C., & McKee, A. C. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00687.x · Cited by 90
Therapeutic Strategies in Alzheimer’s Disease: Ml Muscarinic Agonists
Fisher, A. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.101 · Cited by 85
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
Ramakrishnan, P., Dickson, D. W., & Davies, P. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00109-8 · Cited by 84
Hormonal Regulation of Growth Plate Cartilage
Savendahl, L. S. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087764 · Cited by 82
No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
Wenk, G. L., Quack, G., Moebius, H. J., & Danysz, W. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00411-2 · Cited by 81
Burns, A. S., Byrne, E. J., & Maurer, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09420-5 · Cited by 77
The Environmental Toxin Arsenite Induces Tau Hyperphosphorylation
Giasson, B. I., Sampathu, D. M., Wilson, C., Vogelsberg-Ragaglia, V., Mushynski, W. E., & Lee, V. M. ‐. (2002) · Biochemistry · doi:10.1021/bi026813c · Cited by 69
Tau Protein Phosphorylation as a Therapeutic Target in Alzheimers Disease
Lau, L., Schachter, J. B., Seymour, P. A., & Sanner, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607526 · Cited by 62
An Overview of the Etiology, Diagnosis, and Treatment of Alzheimer Disease
Forsyth, E., & Ritzline, P. D. (1998) · Physical Therapy · doi:10.1093/ptj/78.12.1325 · Cited by 62
Tau is central in the genetic Alzheimer–frontotemporal dementia spectrum
Dermaut, B., Kumar‐Singh, S., Rademakers, R., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.09.005 · Cited by 60
Lee, E. B., Leng, L. Z., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.070 · Cited by 52
Li, Q., Cao, C., Chackerian, B., Schiller, J. T., Gordon, M. N., Ugen, K. E., & Morgan, D. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-21 · Cited by 50
Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins
Sergeant, N., Bussière, T., Vermersch, P., Lejeune, J. P., & Delacourte, A. (1995) · Neuroreport · doi:10.1097/00001756-199511000-00028 · Cited by 49
Latimer, D. A., Gallo, J.-M., Lovestone, S., Miller, C. C. J., Hugh Reynolds, C., Marquardt, B., Stabel, S., Woodgett, J. R., & Anderton, B. H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00434-b · Cited by 48
Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening
Raskind, M. A., Kumar, V., Malaty, L. I., Messina, J. C., Hartman, R. D., & Anand, R. (2000) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v02n0406 · Cited by 44
Auguste D. and Alzheimer's Disease
O’Brien, C. (1996) · Science · doi:10.1126/science.273.5271.28 · Cited by 42
Maier, M., Seabrook, T. J., & Lemere, C. A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.06.018 · Cited by 42
Future directions in the treatment of Alzheimer?s disease
Bullock, R. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.4.303 · Cited by 40
Leverone, J. F., Spooner, E. T. C., Lehman, H. K., Clements, J. D., & Lemere, C. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00754-5 · Cited by 40
Iqbal, K., & Grundke, I. (2004) · Current Drug Targets · doi:10.2174/1389450043345254 · Cited by 37
Alzheimer’s Aβ vaccination of rhesus monkeys (Macaca mulatta)
Gandy, S., DeMattos, R. B., Lemere, C. A., Heppner, F. L., Leverone, J. F., Aguzzi, A., Ershler, W. B., Dai, J., Fraser, P., George‐Hyslop, P. S., et al. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.12.002 · Cited by 36
PARP-1 inhibition to treat cancer, ischemia, inflammation
Graziani, G., Battaini, F., & Zhang, J. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.007 · Cited by 36
Zurbriggen, R., Amacker, M., Kammer, A. R., Westerfeld, N., Borghgraef, P., LEUVEN, F. V., der Auwera, I. V., & Wera, S. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:2:157 · Cited by 25
CHARTIERHARLIN, M., CRAWFORD, F., Houlden, H., WARREN, A., Hughes, D., FIDANI, L., Goate, A., Rossor, M. N., Roques, P. K., Hardy, J., et al. (1991) · UCL Discovery (University College London) · Cited by 23
Ho, D. T., Shayan, H., & Murphy, T. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010106.x · Cited by 22
Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study
Etminan, M., & Fitzgerald, A. S. M. (2019) · Cited by 21
Solomon, B. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.034 · Cited by 16
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
[The French Revolution and mental troubles 1789-1799].
Jc, S. (1997) · PubMed · Cited by 4
Cited by
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 631
Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00767-8 · Cited by 401
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H.-Y., Lamberto, G. R., Fredenburg, R. A., Lansbury, P. T., Fernandez, C. O., Eliezer, D., Zweckstetter, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800747200 · Cited by 363
Metadata
- Authors
- Klafki, H.-W., Staufenbiel, M., Kornhuber, J., & Wiltfang, J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-29
- Volume
- 129
- Issue
- 11
- Pages
- 2840-2855
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2017606063
- Cited by
- 362
- References
- 246
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.